Phase 1 Test-retest Evaluation of [18F]MNI-958 PET

Status:
Completed

Trial end date:
2020-02-06

Target enrollment:

Participant gender:

The overall goal of this protocol is to evaluate [18F]MNI-958 also known as APN-0000455 or PM-PBB3, a tau targeted radiopharmaceutical.

Phase 1

Invicro